Cytomel and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytomel (liothyronine sodium) and Phenergan (promethazine hydrochloride). Common drug interactions include dizziness among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Cytomel and Phenergan. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Cytomel?

Cytomel has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 7,595 Cytomel users. Check the latest studies of Cytomel.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.



On Aug, 08, 2026

48 people who take Cytomel and Phenergan together, and have interactions are studied.

Cytomel and Phenergan drug interactions.

What are the common drug interactions of Cytomel and Phenergan, by gender? *:

female:

  1. Dizziness
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Headache (pain in head)
  4. Muscle spasms (muscle contraction)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Palpitations (feelings or sensations that your heart is pounding or racing)
  7. Back pain
  8. Emotional distress
  9. Pain in extremity
  10. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

male:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Peripheral swelling
  3. Rash macular (small, flat red spots)
  4. Rash pruritic (redness with itching)

What are the common drug interactions of Cytomel and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arrhythmia (irregular heartbeat)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Dizziness
  7. Emotional distress
  8. Headache (pain in head)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypokalaemia (low potassium)

40-49:

  1. Suicidal ideation
  2. Suicide attempt
  3. Upper limb fracture
  4. Application site burn
  5. Application site discolouration
  6. Application site discomfort
  7. Application site erythema (redness of the skin at application site)
  8. Application site irritation
  9. Application site pain
  10. Application site papules (solid elevation of skin with no visible fluid at application site)

50-59:

  1. Myalgia (muscle pain)
  2. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Neck injury
  5. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  6. Obsessive rumination (thinking and worry or rumination is an inability to gain control over recurrent, distressing thoughts, images)
  7. Oedema (fluid collection in tissue)
  8. Overweight
  9. Pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

60+:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Full blood count decreased
  7. Influenza like illness
  8. Injection site erythema (redness at injection site)
  9. Injection site pain
  10. Injection site pruritus (severe itching at injection site)

What are the existing conditions these people have? *

  1. Pain: 13 people, 27.08%
  2. Depression: 12 people, 25.00%
  3. Migraine (headache): 9 people, 18.75%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 16.67%
  5. Stress And Anxiety: 6 people, 12.50%
  6. Hypersensitivity: 6 people, 12.50%
  7. Iron Deficiency Anaemia: 4 people, 8.33%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 8.33%
  9. Drowsiness: 4 people, 8.33%
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cytomel and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cytomel and Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cytomel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytomel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on liothyronine sodium and promethazine hydrochloride (the active ingredients of Cytomel and Phenergan, respectively), and Cytomel and Phenergan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: